US Securities and Exchange Commission+Research and Development Expense+Agios Pharmaceuticals Inc+2019
Actions: add_circle created | edit updated | remove_circle deleted | build unsaved draft
Content changes: Additions | Subtractions
-
+Source
Source-000147401Source-000147400
-
AnswerUS Securities and Exchange Commission+Research and Development Expense+Agios Pharmaceuticals Inc+2019empty
-
MoneyValue+values410894000
-
List+SourceSource-000147401